Regeneron
Manufacturing · New York, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
777 Old Saw Mill River Rd, Tarrytown, Ne...Phone Number
(914) 847-7000Website
www.regeneron.comRevenue
$15.5 BillionStock Symbol
REGNIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
3
3
2
1
1
About Regeneron
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.Explore more
Regeneron Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Regeneron your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Regeneron has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Regeneron
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Regeneron recently announced quarterly report
Product Launch: Get notified when Regeneron launches new products
Regeneron, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Regeneron had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Regeneron has new funding data
Check out if Regeneron is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Explore company insights
Get a deeper look into Regeneron's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Regeneron is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Regeneron is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Regeneron.
Regeneron financials insights
Gather financial insights about Regeneron, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
1991
Stock Offering
$91.4M
2010
Stock Offering
$174.7M
2011
Debt
$400M
Regeneron Tech Stack
A closer look at the technologies used by Regeneron
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Product Development, Medical Research, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Regeneron News & Media
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Regeneron (REGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 9/14/2026REGN Deadline Alert: Levi & Korsinsky Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026
Important Notice Regarding Alleged Phase III Fianlimab-Libtayo Clinical Trial Risk Misrepresentations. The lawsuit alleges Regeneron investors overpaid while the Company characterized slowing event accrual as potentially favorable, even as the study allegedly faced heightened risk of...REGN UPCOMING DEADLINE: SueWallSt Alerts Regeneron Pharmaceuticals, Inc. Stockholders of Securities Class Action - Contact the Firm
Time-Sensitive: Allegations focus on Regeneron's statements about clinical differentiation in the Phase III Fianlimab-Libtayo Study and the last-minute protocol amendment used to force a trial readout Time-Sensitive: Allegations focus on Regeneron's statements about clinical differentiation in the Phase III Fianlimab-Libtayo Study and the last-minute protocol amendment used to force a trial readoutBronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
New class action for Regeneron (REGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 9/14/2026
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Regeneron
Sign Up For FreeTo access detailed company insights
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.... Read More
